Pathologic Complete Response And 3-Year Survival With Or Without Pertuzumab Using Real-World Data Of Stage Ii And Iii Her2-Positive Breast Cancer

CANCER RESEARCH(2021)

Cited 0|Views10
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined